EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Potential of Gut Microbiota and Its Metabolite Short-Chain Fatty Acids in Neonatal Necrotizing Enterocolitis

Naser A Alsharairi iD

Life · 16.02.2023 · 13 (2) · 561

DOI: 10.3390/life13020561 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 16.02.2023. Verfasst von Naser A Alsharairi. Beteiligte Einrichtung: Heart, Mind and Body Research Group, Griffith University, Gold Coast, QLD 4222, Australia. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Short chain fatty acids (SCFAs), the principle end-products produced by the anaerobic gut microbial fermentation of complex carbohydrates (CHO) in the colon perform beneficial roles in metabolic health. Butyrate, acetate and propionate are the main SCFA metabolites, which maintain gut homeostasis and host immune responses, enhance gut barrier integrity and reduce gut inflammation via a range of epigenetic modifications in DNA/histone methylation underlying these effects. The infant gut microbiota composition is characterized by higher abundances of SCFA-producing bacteria. A large number of in vitro/vivo studies have demonstrated the therapeutic implications of SCFA-producing bacteria in infant inflammatory diseases, such as obesity and asthma, but the application of gut microbiota and its metabolite SCFAs to necrotizing enterocolitis (NEC), an acute inflammatory necrosis of the distal small intestine/colon affecting premature newborns, is scarce. Indeed, the beneficial health effects attributed to SCFAs and SCFA-producing bacteria in neonatal NEC are still to be understood. Thus, this literature review aims to summarize the available evidence on the therapeutic potential of gut microbiota and its metabolite SCFAs in neonatal NEC using the PubMed/MEDLINE database.

Schlagwörter

Stichwörter der Autor:innen

gut microbiotametabolitesnecrotizing enterocolitispremature infantshort-chain fatty acids

Autor:innen und Institutionen

  • Heart, Mind and Body Research Group, Griffith University, Gold Coast, QLD 4222, Australia.

ORCID-Profile: Naser A Alsharairi

Zitieren

APA

Alsharairi, N. A. (2023). Therapeutic Potential of Gut Microbiota and Its Metabolite Short-Chain Fatty Acids in Neonatal Necrotizing Enterocolitis. Life, 13(2), 561. https://doi.org/10.3390/life13020561

Vancouver

Alsharairi NA. Therapeutic Potential of Gut Microbiota and Its Metabolite Short-Chain Fatty Acids in Neonatal Necrotizing Enterocolitis. Life. 2023;13(2):561. doi:10.3390/life13020561

BibTeX
@article{Alsharairi2023,
  author = {Alsharairi, Naser A},
  title = {Therapeutic Potential of Gut Microbiota and Its Metabolite Short-Chain Fatty Acids in Neonatal Necrotizing Enterocolitis},
  journal = {Life},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {561},
  doi = {10.3390/life13020561}
}
Kostenlos starten →